|Day Low/High||0.54 / 0.59|
|52 Wk Low/High||0.23 / 1.07|
Markets have perked up just a tad across the board since our last update. As mentioned in an earlier post, Galmed Pharmaceuticals is the second small-cap NASH (nonalcoholic steatohepatitis) play that has soared over the past week. The shares are up ...
Biotech investors should keep a close eye on the progress in this huge potential market.
I've got my eye on steel and biotechnology names to put cash to work.
Thin trading is impeding momentum, but here are 4 stocks on my radar.
Will pension funds sell stocks after their run higher in order to maintain the same allocation levels to bonds and equities?
The market seems to be severely discounting DynaVax's chances of approval for its hep-B treatment.
Here we go. By Bret Jensen The market is slightly up across the board in the first 30 minutes of trading, and the 10-year Treasury yield is approaching 2.65%. Deckers Outdoor (DECK) is nicely up due to an upgrade at Wells Fargo, which now has price ...